Institutional investors purchased a net $1.6 million shares of PCYC during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 76.98% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 2.1 Million shares of Pharmacyclics Inc
JANUS CAPITAL MANAGEMENT LLC Bought 596.8 Thousand shares of Pharmacyclics Inc
FEDERATED GLOBAL INVESTMENT MANA... Bought 375.8 Thousand shares of Pharmacyclics Inc